سوق البروتينات - النمو والاتجاهات وتأثير COVID-19 والتوقعات (2023 - 2028)

Table of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Deliverables

   2. 1.2 Study Assumptions

   3. 1.3 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand for Personalized Medicine

      2. 4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics

      3. 4.2.3 Technological Advancements

   3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Instruments

   4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. MARKET SEGMENTATION

   1. 5.1 By Product & Services

      1. 5.1.1 Instrumentation Technology

         1. 5.1.1.1 Spectroscopy

         2. 5.1.1.2 Chromatography

         3. 5.1.1.3 Electrophoresis

         4. 5.1.1.4 Protein Microarrays

         5. 5.1.1.5 X-Ray Crystallography

         6. 5.1.1.6 Other Instrumentation Technologies

      2. 5.1.2 Reagents

      3. 5.1.3 Software and Services

   2. 5.2 By Application

      1. 5.2.1 Clinical Diagnostics

      2. 5.2.2 Drug Discovery

      3. 5.2.3 Other Applications

   3. 5.3 Geography

      1. 5.3.1 North America

         1. 5.3.1.1 United States

         2. 5.3.1.2 Canada

         3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

         1. 5.3.2.1 Germany

         2. 5.3.2.2 United Kingdom

         3. 5.3.2.3 France

         4. 5.3.2.4 Italy

         5. 5.3.2.5 Spain

         6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

         1. 5.3.3.1 China

         2. 5.3.3.2 Japan

         3. 5.3.3.3 India

         4. 5.3.3.4 Australia

         5. 5.3.3.5 South Korea

         6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

         1. 5.3.4.1 GCC

         2. 5.3.4.2 South Africa

         3. 5.3.4.3 Rest of Middle-East & Africa

      5. 5.3.5 South America

         1. 5.3.5.1 Brazil

         2. 5.3.5.2 Argentina

         3. 5.3.5.3 Rest of South America

6. 6. COMPETITIVE LANDSCAPE

   1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies, Inc.

      2. 6.1.2 Bio-Rad Laboratories, Inc.

      3. 6.1.3 Bruker Corporation

      4. 6.1.4 Danaher Corporation

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Promega Corporation

      8. 6.1.8 Thermo Fisher Scientific, Inc.

      9. 6.1.9 Waters Corporation

   *List Not Exhaustive

7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS